HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. ("HTG") is a provider of instruments, reagents, and services for molecular profiling applications. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary nuclease protection chemistry. In 2014, the company launched the HTG EdgeSeq system that combines the power of
HTG EdgeSeq chemistry and automation with next-generation sequencing (NGS) technology. In 2016, the VERI/O Laboratory Services were introduced to support biopharma clients in research and companion diagnostic development using retrospective samples. Most recently, in 2017, HTG introduced its new DNA mutations chemistry available exclusively in the VERI/O Laboratory Services.
Benefits may vary per position and employment status
Job Openings with HTG Molecular Diagnostics, Inc.
We currently do not have any open positions, but please check back soon.
Join our Talent Network to be considered for future opportunities at HTG Molecular Diagnostics, Inc.